Clinical trials
Recruiting Depressive Disorder trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Max-Planck-Institute of Psychiatry | 3 |
| Eli Lilly and Company | 2 |
| Ludwig-Maximilians - University of Munich | 2 |
| Cybin IRL Limited | 1 |
| Dr. Nils B. Kroemer | 1 |
| Friedrich-Alexander-Universität Erlangen-Nürnberg | 1 |
| Health and Medical University Potsdam | 1 |
| Philipps University Marburg | 1 |
| Seaport Therapeutics | 1 |
| Technical University of Munich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Depressive Disorder | 14 |
| Major Depressive Disorder | 6 |
| Mood Disorders | 4 |
| Anxiety Disorders | 3 |
| Anhedonia | 1 |
| Bipolar Disorder | 1 |
| Lymphoma, Follicular | 1 |
| Neuroinflammatory Diseases | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.